Arch Capital Group Ltd. (ACGL) — Q2 2026 Earnings Preview

Earnings Date: July 28, 2026 (After Market Close) | Conference Call: July 29, 2026 at 10:00 AM ET Prepared: July 28, 2026

1. Earnings Preview

Key Takeaway: Setup is modestly constructive — consensus is a manageable bar after post-Q1 estimate resets, but the single biggest swing factor is the magnitude of property cat rate declines at mid-year renewals and their impact on net premiums written.

Heading into Q2 2026, the consensus bar for ACGL looks achievable: operating EPS of ~$2.47 and net premiums written of ~$4.22B represent a modest step-down from Q1's $2.50 EPS beat, and management's own commentary at Q1 earnings telegraphed continued competitive headwinds in property cat and flat-to-declining top-line growth in insurance. Management's tone since last earnings has been cautiously disciplined — the company confirmed at Q1 that mid-year property cat renewals (6/1 and 7/1) would remain competitive, with double-digit rate declines expected, and that the operating expense ratio would remain elevated in Q2 before normalizing in H2; both of these are already embedded in consensus. Estimate revisions have drifted modestly lower since the Q1 print (Q2 EPS consensus slipped from $2.41 to $2.47 on a net basis, with FY 2026 EPS trimmed from $9.35 to $9.28), suggesting the street has already absorbed the top-line headwinds. The stock has recovered sharply from its post-Q1 sell-off (down ~5% on April 29) and is now up ~7% since last earnings, outperforming the insurance ETF (IAK, +12%) and broadly in line with the S&P 500 (+4%), implying the market has partially re-rated the stock on capital return optionality rather than premium growth. The key wildcard is Iran conflict losses — management guided to additional Q2 losses from political violence and war-on-land lines out of London, and the size of that charge relative to the cat load will be the primary source of EPS surprise in either direction.

2. KPIs & Consensus Expectations

Key Takeaway: Consensus is a low-to-moderate bar on EPS (street already pricing in rate headwinds and elevated expenses), but net premiums written is the bigger swing factor — any upside surprise there would signal better-than-feared mid-year renewal outcomes and likely drive the stock.

Table 1 — Q2 2026 Current Quarter Snapshot (All Key KPIs)

KPI

Q2 2025 Actual (Prior Year)

Q1 2026 Actual (Last Quarter)

Q2 2026 Consensus Estimate

YoY Change

Guidance / Mgmt Commentary

Consensus vs. Guidance

EPS — Diluted Operating ($)

$2.58

$2.50

$2.47

-4.3% YoY

No explicit Q2 guidance; mgmt flagged elevated OpEx in Q2 before H2 normalization

N/A — no numeric guidance

Net Premiums Written ($B)

$4.35B

$4.35B

$4.22B

-3.0% YoY

Mgmt guided ~$250M NPW headwind from MCE non-renewals throughout 2026; mid-year cat renewals expected competitive

Consensus below implied run-rate; reflects rate declines + MCE drag

Combined Ratio — Ex-Cat, Ex-PYD (%)

80.8%

82.4%

82.2%

+140 bps YoY

Mgmt: rates just below trend; margins sustainable near-term; OpEx elevated in Q2

Consensus roughly in line with mgmt tone

Underwriting Income ($M)

$818M

$728M

$689M

-15.8% YoY

No explicit guidance; Q1 was impacted by MCE transition costs; Q2 still elevated

Consensus below Q2 2025 actual; reflects competitive market

Net Investment Income ($M)

$405M

$408M

$425M

+5.0% YoY

~$48B portfolio; short duration; mgmt expects modest sequential improvement

Consensus above Q1 actual; modest tailwind expected

Operating ROE (%)

18.2%

15.4%

15.0%

-320 bps YoY

Mid-teens ROE target; mgmt building excess capital for return

Consensus in line with mgmt mid-teens framing

Book Value Per Share ($)

$59.17

$66.19

$68.16

+15.2% YoY

Mgmt repurchased $783M in Q1; $311M additional in Q2 through late April; $6B total authorization

Consensus implies continued BVPS growth despite buybacks

Sources: Visible Alpha consensus and actuals data. All consensus figures as of latest available (July 2026).

Table 2 — Beat/Miss History (Last 8 Quarters, Top 2 KPIs)

KPI 1: EPS — Diluted Operating ($)

Quarter

Reported

Consensus

Surprise %

Result

Q1 2026

$2.50

$2.45

+2.0%

Beat

Q4 2025

$2.98

$2.54

+17.3%

Beat

Q3 2025

$2.77

$2.18

+27.1%

Beat

Q2 2025

$2.58

$2.32

+11.2%

Beat

Q1 2025

$1.54

$1.31

+17.6%

Beat

Q4 2024

$2.26

$1.87

+20.9%

Beat

Q3 2024

$1.99

$2.00

-0.5%

In-Line / Slight Miss

Q2 2024

$2.57

$2.21

+16.3%

Beat

KPI 2: Net Premiums Written ($B)

Quarter

Reported ($B)

Consensus ($B)

Surprise %

Result

Q1 2026

$4.35B

$4.50B

-3.4%

Miss

Q4 2025

$3.65B

$3.96B

-7.8%

Miss

Q3 2025

$3.96B

$4.40B

-9.9%

Miss

Q2 2025

$4.35B

$4.30B

+1.2%

Beat

Q1 2025

$4.52B

$4.78B

-5.5%

Miss

Q4 2024

$3.82B

$3.92B

-2.5%

Miss

Q3 2024

$4.05B

$3.83B

+5.7%

Beat

Q2 2024

$3.78B

$3.94B

-4.1%

Miss

Pattern: ACGL has beaten EPS consensus in 7 of the last 8 quarters with an average beat of ~14%, reflecting consistently conservative street estimates; however, net premiums written has missed consensus in 6 of the last 8 quarters as the market has been slow to reset top-line expectations for the competitive rate environment — this persistent NPW miss pattern means the bar on premiums is now more appropriately set heading into Q2 2026. Source: Visible Alpha consensus and actuals data.

3. Guidance & Commentary Evolution

Key Takeaway: No formal numeric guidance was revised post-Q1 earnings, but management's tone has shifted toward capital return as the primary near-term priority as reinsurance growth has tapered materially; the $3B buyback authorization increase and $311M of Q2 repurchases already executed are the most important post-earnings development.

Metric

Initial Guidance (Q1 2026 Earnings Call, Apr 28)

Revised Guidance

Current Consensus

Note

Operating EPS (Q2 2026)

No explicit guidance; mgmt flagged elevated OpEx in Q2 before H2 normalization

$2.47

No post-earnings revision; consensus drifted slightly lower post-Q1 print

Net Premiums Written (Q2 2026)

~$250M NPW headwind from MCE non-renewals throughout 2026; mid-year renewals expected competitive with double-digit cat rate declines

$4.22B

RNR Q2 2026 results confirmed property cat rates down high-teens at mid-year — consistent with ACGL guidance

Operating Expense Ratio

Elevated in Q2 due to MCE systems cutover costs; expected to normalize toward historical levels in H2 2026

82.2% ex-cat ex-PYD combined ratio (consensus)

Q2 still expected to carry transition costs; H2 normalization is the key margin catalyst

Share Repurchases

$783M repurchased in Q1; Board authorized additional $3B (total $6B authorization); $311M repurchased in Q2 through April 29

N/A — not in VA consensus

Capital return is front and center; mgmt confirmed no structural limits to returning all or more than operating income

Property Cat PML

Peak zone PML flat at $1.9B (8.2% of tangible equity) at 4/1; more meaningful changes expected at 6/1 and 7/1 depending on rate outcomes

N/A

7/1 renewal outcomes will be disclosed on Q2 call; key read on cat exposure trajectory

Iran Conflict Losses

Additional Q2 losses expected from political violence, war-on-land, terror lines out of London; Q1 losses absorbed within cat load

N/A — not in VA consensus

Key wildcard for Q2 EPS; industry loss estimated at several billion dollars; Arch selectively wrote incremental business at spiked rates

MidCorp (MCE) Growth

Systems migration complete; core upper middle market business stabilizing; meaningful growth contribution is a 2027 story

N/A

No change to tone; Q2 will still reflect MCE non-renewal drag (~$250M annualized)

4. Guidance vs. Estimate Revision Tracker

Key Takeaway: Estimates for Q2 2026 and FY 2026 have drifted modestly lower since the Q1 print, with EPS trimmed ~2% and NPW down ~1% — revisions are tracking management's cautious tone on top-line growth, and the gap between consensus and guidance is not a meaningful risk or cushion in either direction.

KPI (Period)

Estimate (May 5, 2026 — 5 Days Post Q1 Print)

Current Consensus

Estimate Δ (%)

Initial Guidance (Q1 Call)

Current Guidance

Guidance Δ

Consensus vs. Guidance (%)

EPS — Diluted Operating (Q2 2026)

$2.41

$2.47

+2.5%

No explicit guidance

No explicit guidance

N/A

N/A

EPS — Diluted Operating (FY 2026)

$9.35

$9.28

-0.7%

No explicit guidance

No explicit guidance

N/A

N/A

Net Premiums Written (Q2 2026)

$4.27B

$4.22B

-1.3%

~$250M NPW headwind from MCE non-renewals in 2026; mid-year cat rates expected competitive

Unchanged

Flat

Consensus below guidance-implied run-rate; reflects rate declines

Net Premiums Written (FY 2026)

$16.26B

$16.17B

-0.6%

~$250M NPW headwind from MCE non-renewals in 2026

Unchanged

Flat

Consensus tracking guidance

Combined Ratio Ex-Cat Ex-PYD (Q2 2026)

82.1%

82.2%

+0.1 pts

Elevated OpEx in Q2; normalization in H2

Unchanged

Flat

Consensus in line with mgmt tone

Underwriting Income (Q2 2026)

$655M

$689M

+5.2%

No explicit guidance

No explicit guidance

N/A

N/A

Estimates have been modestly revised upward for Q2 EPS (+2.5%) since the post-Q1 baseline, likely reflecting the strong capital return signal from the $3B buyback authorization, while FY 2026 EPS has been trimmed slightly (-0.7%) as analysts reset for the full-year top-line headwinds. The revision trajectory is orderly and not signaling a material risk in either direction. Source: Visible Alpha consensus and actuals data.

5. Stock Performance

Key Takeaway: ACGL has recovered from its post-Q1 sell-off and is up ~7% since last earnings, but has meaningfully underperformed the insurance ETF (IAK, +12%) — the gap reflects the market rewarding peers with cleaner top-line growth stories while ACGL's premium headwinds weigh on sentiment despite strong EPS and capital return.

Sector ETF used: IAK (iShares U.S. Insurance ETF) — appropriate for ACGL's P&C insurance and reinsurance sub-sector. ACGL is a top holding in IAK. The S&P 500 (SPY) is included as the broad market benchmark.

ACGL vs IAK (Insurance ETF) vs S&P 500 — Indexed to 100 at April 28, 2026 (Last Earnings Date). Source: Stock Price Data.

Performance Summary (April 28 – July 28, 2026): ACGL opened at $97.06 on earnings day (April 28), fell to $92.72 on April 29 (-4.5% day-after reaction), and has since recovered to $103.88 as of July 28 (+7.0% total since last earnings). IAK gained +11.8% over the same period, and SPY gained +3.9%. The stock's underperformance vs. IAK is notable — peers with cleaner premium growth stories (RNR, HG) have been rewarded more. Key events marked: leadership restructure announcement (June 3), $2B debt offering completion (June 9), and Halgan/Schmeiser CEO appointments (June 17). The stock re-rated higher in late June/early July, likely driven by the leadership clarity and the broader insurance sector rally. The stock is now trading at approximately

Valuation context: At ~$104, ACGL trades at approximately 11x NTM operating EPS ($9.28 consensus), a discount to its historical average of ~13-14x and to peers like RNR (~12x). The discount reflects market skepticism on premium growth sustainability, but the aggressive buyback program (which is accretive to EPS and BVPS) provides a floor. The stock is not pricing in a beat — it is pricing in execution on capital return.

6. Peer Commentaries — Q2 2026 Read-Throughs

Key Takeaway: Peer commentary from Q2 2026 reporters (RNR) and Q1 2026 reporters commenting on Q2 outlook (HG, SPNT) paints a consistent picture: property cat rates down high-teens at mid-year, casualty reinsurance under ceding commission pressure, and cyber softening — all headwinds ACGL has already flagged, suggesting consensus is appropriately calibrated. The positive read-through is that underlying underwriting margins remain adequate and benign cat activity is a tailwind.

Note: Only commentary about Q2 2026 market conditions or forward-looking statements made after Q1 2026 earnings is included below. Q1 2026 results commentary (i.e., peers discussing their own Q1 performance) is excluded.

RenaissanceRe (RNR) — Q2 2026 Earnings (Reported July 22–23, 2026)

Most directly relevant peer: RNR is a pure-play reinsurer with significant property cat and casualty reinsurance exposure, making it the highest-quality read-through for ACGL's reinsurance segment.

Hamilton Insurance Group (HG) — Q1 2026 Earnings (Reported May 1, 2026) — Q2 Outlook Commentary

Relevant for: ACGL's property reinsurance and specialty insurance segments; HG is a Bermuda-based specialty insurer/reinsurer with overlapping lines.

SiriusPoint (SPNT) — Q1 2026 Earnings (Reported May 7–8, 2026) — Q2 / Full-Year Outlook Commentary

Relevant for: ACGL's specialty insurance and reinsurance segments; SPNT is a smaller specialty reinsurer with overlapping casualty and property lines.

Peer Read-Through Summary Table

Theme

Peer Signal

ACGL Implication

Direction

Property Cat Rates at Mid-Year

RNR: down high-teens; HG: "more of the same"; SPNT: down ~15%

Consistent with ACGL Q1 guidance; no incremental negative surprise

Neutral

Cat Activity (Q2 2026)

RNR: strong combined ratio of 72.8%; low cat losses; SPNT Q1: benign cat

Positive read for ACGL Q2 cat load; supports EPS beat potential

Positive

Casualty Reinsurance / Ceding Commissions

RNR: increased cession rates; casualty GPW down 15%; HG: sidecar launched

Confirms ceding commission pressure; ACGL's casualty reinsurance NPW likely under pressure

Negative

Casualty Sidecar Market Impact

RNR: impact "negligible" so far; HG: launched $300M sidecar

Near-term headwind confirmed but not yet market-moving; ACGL's concern is valid but not acute

Neutral

Cyber Rate Pressure

RNR: explicit rate pressure in cyber; SPNT: competitive financial/professional lines

Consistent with ACGL's mid-cycle caution on cyber; no incremental surprise

Neutral

E&S Casualty Growth

HG Select: +17% E&S casualty; SPNT: excess casualty still double-digit rate increases

Positive read for ACGL's E&S casualty and specialty lines; growth opportunity intact

Positive

Iran/Middle East Losses

HG: manageable exposure; losses in political violence/terror/marine out of Lloyd's

ACGL's Q2 Iran losses likely concentrated in London specialty book; HG's manageable exposure suggests no systemic industry shock

Neutral / Watch

Prior Year Development

RNR: $199M favorable PYD in property; $58M adverse in casualty (incl. Baltimore Bridge)

Favorable property PYD environment is a positive read; Baltimore Bridge adverse development is a watch item for ACGL's specialty book

Mixed

7. Material News & Developments

Key Takeaway: The most important development since Q1 earnings is the leadership restructuring and CEO appointments (June 17) — elevating segment-level CEOs signals Arch is building for scale in reinsurance and mortgage, and the market reacted positively. The $2B debt offering is a secondary but meaningful capital structure event.

8. Insider Transaction Activity

Key Takeaway: No open-market buys or discretionary sells by senior executives or the CEO/CFO since last earnings — the only notable transaction is a director open-market purchase of $5,300 by Daniel Houston on April 30 (the day after the post-earnings sell-off), which is a modest but directionally positive signal. All other transactions are routine director compensation awards or a gift/transfer by the Chairman.

Name

Title

Transaction Type

Value / Shares

Transaction Date

Note

Houston, Daniel Joseph

Director

Open Market Buy

5,300 shares (~$493K at ~$93/share)

April 30, 2026

Discretionary purchase the day after post-Q1 sell-off; directionally positive signal

Pasquesi, John M.

Chair, Director

Gift / Transfer (Code G)

~$1.007M (gift from LLC to Trust)

June 11, 2026

Internal transfer between related entities (LLC to Trust); not an open-market sale; no economic change in beneficial ownership

Posner, Brian S.

Director

Open Market Sale (Preferred Shares)

3,000 Depositary Shares, Series F

June 3, 2026

Sale of preferred depositary shares (not common equity); limited read-through to common stock outlook

Posner, Brian S.

Director

Open Market Sale (Preferred Shares)

2,000 Depositary Shares, Series G

May 11, 2026

Sale of preferred depositary shares (not common equity); limited read-through to common stock outlook

Multiple Directors (8 individuals)

Directors

Compensation Award (Code A)

2,071–3,398 shares each (routine annual director equity grants)

May 5, 2026

Routine annual director compensation awards; not open-market purchases; no signal value

Summary: Insider activity since last earnings is largely routine (director compensation awards, a gift/transfer by the Chairman, and preferred share sales by one director). The only open-market common equity purchase is Director Houston's $493K buy on April 30 — the day after the post-Q1 sell-off — which is a modest positive signal. No senior management (CEO, CFO, President) transactions are present in the period. The absence of executive selling is neutral-to-positive. No 10b5-1 plan initiations were disclosed in the period.

Source: Insider Transaction Data (SEC Form 4 filings, April 28 – July 28, 2026).